Assessing Multichannel in Blood Cancers report
Exploring the unmet need for improved digital content and channel use in blood cancers
.jpg)
What's included in this report:
- Insights from a quantitative survey of 180 hem-oncs in Europe & US
- An evaluation of the digital channel performance of CALQUENCE, GAZYVA, IMBRUVICA & REVLIMID
- Which brand is executing across digital channels most effectively
- An analysis of how digital content can drive customer experience (and deliver value)
Fill in the form to receive a copy of the full report direct to your inbox
What's included in this report:
- Insights from a quantitative survey of 180 hem-oncs in Europe & US
- An evaluation of the digital channel performance of CALQUENCE, GAZYVA, IMBRUVICA & REVLIMID
- Which brand is executing across digital channels most effectively
- An analysis of how digital content can drive customer experience (and deliver value)
Fill in the form to receive a copy of the full report direct to your inbox